Claudins as biomarkers of differential diagnosis and prognosis of tumors Olga P. PopovaAlla V. KuznetsovaAlexey A. Ivanov Review – Cancer Research 09 July 2021 Pages: 2803 - 2817
The role of metformin on lung cancer survival: the first systematic review and meta-analysis of observational studies and randomized clinical trials Suzan BrancherAna Elisa RibeiroElisabete Weiderpass Review – Cancer Research 15 July 2021 Pages: 2819 - 2836
Relationship between lung function and lung cancer risk: a pooled analysis of cohorts plus Mendelian randomization study Zixuan SuYu JiangWenhua Liang Original Article – Cancer Research 27 July 2021 Pages: 2837 - 2849
Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer Atieh YaghoubiFereshteh AsgharzadehSaman Soleimanpour Original Article – Cancer Research 12 June 2021 Pages: 2851 - 2865
Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C Jin LiuMingyi ZhuQianli Tang Original Article – Cancer Research 04 July 2021 Pages: 2867 - 2877
Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients Eugen BellonKatharina GruppNathaniel Melling Original Article – Cancer Research Open access 19 June 2021 Pages: 2879 - 2884
Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma M. Constanza CamargoMinkyo SongKeitaro Matsuo Original Article – Cancer Research 14 June 2021 Pages: 2885 - 2892
HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer Vic HartMarco SilipoAlison Tyson-Capper Original Article – Cancer Research Open access 16 June 2021 Pages: 2893 - 2912
Association of tumor downstaging after neoadjuvant chemotherapy with survival in patients with locally advanced nasopharyngeal carcinoma: a retrospective cohort study Weifeng WangShaohua PengShengmin Chen Original Article – Cancer Research 23 June 2021 Pages: 2913 - 2922
Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines Karen BräutigamElodie Kabore-WolffFrank Köster Original Article – Cancer Research Open access 29 June 2021 Pages: 2923 - 2933
Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas Gang JiLonglong BaoXiaoyan Zhou Original Article – Cancer Research 13 July 2021 Pages: 2935 - 2944
Treatment of breast and colon cancer cell lines with anti-helmintic benzimidazoles mebendazole or albendazole results in selective apoptotic cell death Jakeb S. S. M. PetersenSarah K. Baird Original Article – Cancer Research 20 June 2021 Pages: 2945 - 2953
Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor Aldo PrawiraThi Bich Uyen LeHung Huynh Original Article – Cancer Research Open access 22 June 2021 Pages: 2955 - 2968
Differential expression of stem cell markers in proliferating cells in glioma Marten RehfeldJakob MatschkeChristian Bernreuther Original Article – Cancer Research Open access 25 June 2021 Pages: 2969 - 2982
Retrospective analysis of cancer-specific gene expression panel for thyroid fine needle aspiration specimens Yongchun WangBrittany A. McKelveyChristopher B. Umbricht Original Article – Cancer Research 24 June 2021 Pages: 2983 - 2991
Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens Fei CaoJiaping ZhengGuoliang Shao Original Article – Cancer Research Open access 24 July 2021 Pages: 2993 - 3002
The advanced development of Cx43 and GAP-43 mediated intercellular networking in IDH1 wildtype diffuse and anaplastic gliomas with lower mitotic rate Aleksandrs KrigersPatrizia MoserChristian F. Freyschlag Original Article – Cancer Research 26 June 2021 Pages: 3003 - 3009
Human papillomavirus (HPV) types 16 and 18 infection and esophageal squamous cell carcinoma: a systematic review and meta-analysis Fausto PetrelliGabriella De SantiAndrea Celotti Review – Clinical Oncology 17 July 2021 Pages: 3011 - 3023
Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases Catalina HoppeMaren FreudingJutta Hübner Review – Clinical Oncology Open access 17 August 2021 Pages: 3025 - 3042
Performance of international prognostic indices in plasmablastic lymphoma: a comparative evaluation Nadine HertelHartmut MerzNiklas Gebauer Original Article – Clinical Oncology Open access 03 March 2021 Pages: 3043 - 3050
Clinical feasibility and oncologic safety of primary endoscopic submucosal dissection for clinical submucosal invasive early gastric cancer Ji Eun NaHyuk LeeJae J. Kim Original Article – Clinical Oncology 05 March 2021 Pages: 3051 - 3061
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials Stefanie Noepel-DuennebackeHendrik JuetteAandrea Tannapfel Original Article – Clinical Oncology Open access 06 March 2021 Pages: 3063 - 3072
Efficacy of three BCG strains (Connaught, TICE and RIVM) with or without secondary resection (re-TUR) for intermediate/high-risk non-muscle-invasive bladder cancers: results from a retrospective single-institution cohort analysis Francesco Del GiudiceGian Maria BusettoEttore De Berardinis Original Article – Clinical Oncology Open access 06 March 2021 Pages: 3073 - 3080
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network Vivien SchäferHelen E. WhiteThomas Ernst Original Article – Clinical Oncology Open access 07 March 2021 Pages: 3081 - 3089
Epidemiology and prognosis of parathyroid carcinoma: real-world data using nationwide cohort Sung Hye KongJung Hee KimChan Soo Shin Original Article – Clinical Oncology 18 March 2021 Pages: 3091 - 3097
Application of four nutritional risk indexes in perioperative management for esophageal cancer patients Pei-yu WangXian-kai ChenYin Li Original Article – Clinical Oncology 09 March 2021 Pages: 3099 - 3111
Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma Zixiang YuHaixing WangYingyong Hou Original Article – Clinical Oncology 08 May 2021 Pages: 3113 - 3121
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma Sojung HanHye Jin ChoiBeom Kyung Kim Original Article – Clinical Oncology 23 April 2021 Pages: 3123 - 3133
A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients? Alessandro LeonettiDaniela CarboneElisa Giovannetti Letter to the Editor 26 April 2021 Pages: 3135 - 3137
Correction to: Stereotactic body radiotherapy for elderly patients (≥ 75 years) with early‑stage non‑small cell lung cancer Zekai ShuBaiqiang DongYuanyuan Chen Correction 23 November 2020 Pages: 3139 - 3139